To screen or not to screen: A volatile issue in lung cancer

Chest

Volumn 123, Issue 6, 2003, Pages 1788-1792

  Ost, David ^a   Shah, Rakesh D ^a   Fein, Daniel ^a   Fein, Alan M ^a,b  

^a North Shore Long Isl Jewish H   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; EDITORIAL; HUMAN; LUNG CANCER; PRIORITY JOURNAL;

EID: 0038805552     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.6.1788     Document Type: Editorial

References (17)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics 2002. CA Cancer J Clin 2002; 52:23-47
2. American Cancer Society. Cancer prevention and early detection worksheet for men. Available at: www.cancer.org. Accessed April 24, 2003
3. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351:1242-1245
4. Henschke CI, McCauley DI, Yankelvitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105
5. Reich JM. Improved survival and higher mortality: the conundrum of lung cancer screening. Chest 2002; 122:329-337
6. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000; 92:1290-1292
7. Flehinger BJ, Melamed MR, Zaman MG, et al. Early lung cancer detection: results of the initial screen (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984; 130:555-560
8. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the John Hopkins study. Am Rev Respir Dis 1984; 130:549-554
9. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984; 130:561-565
10. Marcus PM, Bergstralh EJ, Faferstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 20:1308-1316
11. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002; 122:15-20
12. Henschke CI, Yankelvitz DF. CT screening for lung cancer. Radiol Clin North Am 2000; 38:487-495
13. Kersting M, Friedl C, Kraus A, et al. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 2000; 18:3221-3229
14. Mulshine JL, Scott F. Molecular markers in lung cancer detection: new screening tools. Chest 1995; 107(suppl):280S-286S
15. Payne PW, Sebo TG, Doudkine A, et al. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clin Proc 1997; 72:697-704
16. Prakash UBS. Advances in bronchoscopic procedures. Chest 1999; 116:1403-1408
17. Phillips M, Gleeson K, Hughes MB, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999; 353:1930-1933